Savara (SVRA) Accumulated Depreciation & Amortization (2011 - 2025)

Savara (SVRA) reported Accumulated Depreciation & Amortization of $2.3 million for Q4 2025, up 7.91% year-over-year from $2.2 million in Q4 2024, and up 7.91% on a QoQ basis from $2.2 million in Q4 2024.

Savara (SVRA) has 15 years of Accumulated Depreciation & Amortization data on file, last reported at $2.3 million in Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 7.91% year-over-year to $2.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.3 million (up 7.91% YoY) and the FY2025 annual result came in at $2.3 million, up 7.91% from the prior year.
  • Accumulated Depreciation & Amortization rose to $2.3 million in Q4 2025 per SVRA's latest filing, from $2.2 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $2.3 million in Q4 2025 and bottomed at $1.9 million in Q4 2022.
  • The 5-year median for Accumulated Depreciation & Amortization is $2.1 million (2021), against an average of $2.1 million.
  • The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization retreated 7.5%; it then rose 7.91% in 2025.
  • Tracing SVRA's Accumulated Depreciation & Amortization over 5 years: stood at $2.1 million in 2021, then dropped by 7.5% to $1.9 million in 2022, then advanced by 4.63% to $2.0 million in 2023, then increased by 7.46% to $2.2 million in 2024, then increased by 7.91% to $2.3 million in 2025.
  • Per Business Quant, the three latest SVRA Accumulated Depreciation & Amortization figures stand at $2.3 million (Q4 2025), $2.2 million (Q4 2024), and $2.0 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Savara 1.30 Bn 1.30 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 2.33 Mn
Dec 31, 2025 2.33 Mn
Dec 31, 2024 2.16 Mn
Dec 31, 2024 2.16 Mn
Dec 31, 2023 2.01 Mn
Dec 31, 2023 2.01 Mn
Dec 31, 2022 1.92 Mn
Dec 31, 2022 1.92 Mn
Dec 31, 2021 2.08 Mn
Dec 31, 2021 2.08 Mn
Dec 31, 2020 1.97 Mn
Dec 31, 2020 1.97 Mn
Dec 31, 2019 1.67 Mn
Dec 31, 2019 1.67 Mn
Dec 31, 2018 1.37 Mn
Dec 31, 2018 1.37 Mn
Dec 31, 2017 851,000.00
Dec 31, 2017 851,000.00
Dec 31, 2016 504,000.00
Dec 31, 2016 504,000.00
Dec 31, 2015 339,000.00
Dec 31, 2015 339,000.00
Dec 31, 2014 344,000.00
Dec 31, 2014 344,000.00
Dec 31, 2013 262,000.00
Dec 31, 2013 262,000.00
Dec 31, 2012 320,545.00
Dec 31, 2012 320,545.00
Dec 31, 2011 274,187.00
Dec 31, 2011 274,187.00